Search Results

Read CSL Behring's Vita stories from 2022

https://www.csl.com/we-are-csl/vita-original-stories/2022/stat-news-highlights-samrna

Read more news from CSL

https://newsroom.csl.com/

News Releases |

https://newsroom.csl.com/2022-08-17-CSL-Announces-Positive-Top-Line-Phase-3-Results-for-Garadacimab-as-Preventive-Treatment-in-Patients-with-Hereditary-Angioedema-HAE

News Releases |

https://newsroom.csl.com/csl-behring

News Releases |

https://newsroom.csl.com/2020-11-05-CSL-Behring-Publishes-Design-for-First-Ever-Outcomes-Study-of-ApoA-I-to-Reduce-Risk-of-Cardiovascular-Events-in-Heart-Attack-Patients

News Releases |

https://newsroom.csl.com/csl-seqirus

News Releases |

https://newsroom.csl.com/2023-09-26-CSL-Seqirus-secures-multi-year-pandemic-preparedness-agreement-as-part-of-its-continued-partnership-with-the-UK-government

News Releases |

https://newsroom.csl.com/2024-05-30-On-Pandemic-Preparedness

News Releases |

https://newsroom.csl.com/2024-06-11-CSL-Seqirus,-a-Proud-Champion-of-Pandemic-Preparedness,-Signs-an-Agreement-with-the-European-Commission-to-Provide-Pre-Pandemic-Vaccines-to-the-EU

News Releases |

https://newsroom.csl.com/csl-vifor